Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA323163
Max Phase: Preclinical
Molecular Formula: C16H15N3O2S
Molecular Weight: 313.38
Molecule Type: Small molecule
Associated Items:
ID: ALA323163
Max Phase: Preclinical
Molecular Formula: C16H15N3O2S
Molecular Weight: 313.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1nc2sc3c(c2c(=O)o1)CCN(Cc1ccccc1)C3
Standard InChI: InChI=1S/C16H15N3O2S/c17-16-18-14-13(15(20)21-16)11-6-7-19(9-12(11)22-14)8-10-4-2-1-3-5-10/h1-5H,6-9H2,(H2,17,18)
Standard InChI Key: HBUJNXVMIKVGHN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 313.38 | Molecular Weight (Monoisotopic): 313.0885 | AlogP: 2.39 | #Rotatable Bonds: 2 |
Polar Surface Area: 72.36 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 6.66 | CX LogP: 3.01 | CX LogD: 2.94 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.79 | Np Likeness Score: -1.50 |
1. Pietsch M, Gütschow M.. (2005) Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition., 48 (26): [PMID:16366609] [10.1021/jm0508639] |
Source(1):